A dsRNA active ingredient (ledprona, marketed as Calantha®) targeting proteasome subunit β5 (PSMB5) achieves the efficient suppression of PSMB5 gene expression and protein synthesis, causing CPB mortality and protecting crop plants in the laboratory and field. This evidence concerns the gene PSMB5 and carotid plaque build.